Real-time enrollment status for this hereditary angioedema clinical trial
Current Status
Completed
Checked: March 2, 2026 at 12:06 PM UTC
| NCT Number | NCT06467084 |
| Recruiting Status | Completed |
| Condition | Hereditary Angioedema |
| Phase | Clinical Trial |
| Target Enrollment | 48 participants |
| Active Locations | 10 sites in the US |
| Sponsor | KalVista Pharmaceuticals, Ltd. |
| Last Updated on CT.gov | January 23, 2026 (Jan 23, 2026) |
As of March 2, 2026: Clinical trial NCT06467084 is currently completed participants. This clinical trial study for hereditary angioedema is not currently accepting new participants at 10 locations across the United States. The study is sponsored by KalVista Pharmaceuticals, Ltd.. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06467084 is currently completed. The study may resume recruiting in the future.
This trial is recruiting at 10 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06467084 was last updated Jan 23, 2026 (January 23, 2026). HelloStudys verifies this status automatically.